GAM
MRNA icon

Gemmer Asset Management’s Moderna MRNA Stock Holding History

Gemmer Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-44
Closed -$7K – 746
2022
Q1 		$7K Buy
44
+1
+2% +$168 ﹤0.01% 841
2021
Q4 		$11K Buy
43
+14
+48% +$4.09K ﹤0.01% 711
2021
Q3 		$11K Sell
29
-15
-34% -$5.53K ﹤0.01% 671
2021
Q2 		$10K Hold
44
– – ﹤0.01% 786
2021
Q1 		$6K Sell
44
-16
-27% -$2.32K ﹤0.01% 985
2020
Q4 		$6K Hold
60
– – ﹤0.01% 910
2020
Q3 		$4K Sell
60
-40
-40% -$2.79K ﹤0.01% 975
2020
Q2 		$6K Buy
100
+75
+300% +$4.11K ﹤0.01% 788
2020
Q1 		$1K Buy
+25
New +$575 ﹤0.01% 1193

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Gemmer Asset Management's MRNA Position: Q2 2022 in Review

Gemmer Asset Management sold out of Moderna (MRNA) in Q2 2022, closing a stake of 44 shares — an estimated $7K sold.

Gemmer Asset Management first reported a position in MRNA in Q1 2020 and held it in 9 quarters. The position peaked at $11K in Q4 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Gemmer Asset Management reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Gemmer Asset Management sold 44 Moderna shares in Q2 2022, an estimated $7K.
  • Gemmer Asset Management first reported a position in Moderna in Q1 2020 and held it in 9 quarters.
  • Gemmer Asset Management's Moderna position peaked at $11K in Q4 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.